ConductScience.org, home

Paper38521

The MEA-I syndrome: an all or none phenomenon?

Majewski JT and 1 other. Surgery, 1979. Cited by 105 papers, by iCite.

Cite this record

ConductScience Library. The MEA-I syndrome: an all or none phenomenon? Papers, record 38521. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38521

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The MEA-I syndrome: an all or none phenomenon?
PubMed
Journal
Surgery
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
105
iCite
Relative citation ratio, by iCite
3.97
iCite
Revised in PubMed
2006-11-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Majewski JTJ T
2Wilson SDS D

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple Endocrine NeoplasiaMajor topic
Adrenal Gland Neoplasms
Adult
Aged
Female
Humans
Male
Middle Aged
Pancreatic Neoplasms
Parathyroid Neoplasms
Pedigree
Pituitary Neoplasms

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.

PMIDTitleJournalYearIn PapersSource
41463062Current Medical Controversies in Zollinger-Ellison Syndrome.Biomedicines2025https://conductscience.org/library/papers/41463062PubMed
33312161Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/33312161PubMed
28426491Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.Pancreas2017https://conductscience.org/library/papers/28426491PubMed
26597365Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.Ann Surg Oncol2016https://conductscience.org/library/papers/26597365PubMed
26363542Multiple Endocrine Neoplasia: Genetics and Clinical Management.Surg Oncol Clin N Am2015https://conductscience.org/library/papers/26363542PubMed
23645327
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
Medicine (Baltimore)2013https://conductscience.org/library/papers/23645327PubMed
19949948Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients.World J Surg2010https://conductscience.org/library/papers/19949948PubMed
18798544Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.Cancer2008https://conductscience.org/library/papers/18798544PubMed
16432361Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas.Ann Surg2006https://conductscience.org/library/papers/16432361PubMed
16327485Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.Ann Surg2005https://conductscience.org/library/papers/16327485PubMed
11573043Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.Ann Surg2001https://conductscience.org/library/papers/11573043PubMed
10816635Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.Ann Surg2000https://conductscience.org/library/papers/10816635PubMed
7655733Multiple endocrine neoplasia type 1 (MEN 1) revisited.Virchows Arch1995https://conductscience.org/library/papers/7655733PubMed
7594219Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome.J Endocrinol Invest1995https://conductscience.org/library/papers/7594219PubMed
6786616Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6786616PubMed
6207668MEN I pancreas: a histological and immunohistochemical study.World J Surg1984https://conductscience.org/library/papers/6207668PubMed
2889587Malignant insulinoma with metastasis to gallbladder and bone, accompanied by past history of peptic ulcer and hyperthyroidism.Dig Dis Sci1987https://conductscience.org/library/papers/2889587PubMed
2884784Serum gastrin, calcitonin, and prolactin as markers of multiple endocrine neoplasia syndromes in patients with primary hyperparathyroidism.World J Surg1987https://conductscience.org/library/papers/2884784PubMed
2575183Multiple endocrine neoplasia.Jpn J Surg1989https://conductscience.org/library/papers/2575183PubMed
1675226Multiple endocrine neoplasia type I: general features and new insights into etiology.J Endocrinol Invest1991https://conductscience.org/library/papers/1675226PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38521

GET https://conductscience.org/api/papers/v1/38521/cited_by?page=2